Showing results (761-770 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|August 26, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- miceCristina Di Giorgio, Ginevra Urbani, Carmen Massa, et al.
Hepatology Communications|August 27, 2025
Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosisBerkay Senkalfa, Melanie Gloor, Ronja Podlaszewski, et al.
Hepatology Communications|April 19, 2023
A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primatesDaniel Stone, Nadja Meumann, Anne-Sophie Kuhlmann, et al.
Hepatology Communications|January 29, 2026
Hyperammonemia predicts the development of liver-related events in a prospective cohort of stable cirrhosis patients and the external validation of the AMMON-OHE scoreLoi Pooi Ling, Xuan Han Koh, Daniel Lim Yan Zheng, et al.
Hepatology Communications|January 29, 2026
Rifaximin reduces rehospitalization risk in patients with cirrhosis and overt hepatic encephalopathyArun B Jesudian, Patrick Gagnon-Sanschagrin, Rebecca Bungay, et al.
Hepatology Communications|January 16, 2026
Preclinical development of mesothelin-targeting CAR T cells for the treatment of cholangiocarcinomaJinchutha Duangdara, Shaoli Lin, Jessica Hong, et al.
Hepatology Communications|January 21, 2026
Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implicationsZihan Wang, Zixuan Cao, Yunsheng Dong, et al.
Hepatology Communications|January 16, 2026
A systematic review and meta-analysis of the use of human albumin solution for treating the complications of liver cirrhosisReem M AlSowaiegh, Khalifa A Yusuf, Nick Freemantle, et al.
Hepatology Communications|January 6, 2026
Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trialYunosuke Kawaguchi, Keita Terui, Takashi Fumita, et al.
Hepatology Communications|January 6, 2026
Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare systemBasim Ali, Ronald Samuel, Jennifer R Kramer, et al.
Pageof 179